NCT06250608Completed
Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.
Evaluation of Cerebral Oxygen Saturation(rSO2) Measurements Between Frontal Lesion Area and Normal Area of Brain by Pulse Oximetry(NIRSITX) Using Near-infrared Spectroscopy in Acute Ischemic Stroke Patients, Prospective, Multi-center, Non-randomized, Open-label, Exploratory Clinical Trial.
Source: ClinicalTrials.gov · Last updated 20 Apr 2026
Brief summary (registry, in English)
The clinical trial is for acute ischemic stroke patients measuring cerebral oxygen saturation (rSO2) values using pulse oximeter of near-infrared spectroscopy in the frontal lesion area and normal area of brain. The purpose of the clinical trial is to compare differences in cerebral oxygen saturation values, and the efficacy and safety are evaluated through additional exploratory clinical trials.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 35 (actual)
- First submitted
- 30 Jan 2024
- Start date
- 15 Mar 2024
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- OBELAB, Inc.
- Diseases
- Stroke
- NCT number
- NCT06250608
What you commit to
- Study type: Interventional
- Participants enrolled: 35
- From 15 Mar 2024 to the primary completion date, 31 Mar 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients without brain imaging result
- Patients diagnosed with jaundice (hyperbilirubinemia) with abnormal skin color - Patients who find it difficult to wear medical devices for clinical trial on their foreheads
- Patients who has skull fractures of external shape not maintained normal
- Patients who does not agree to participate in this clinical trial
- Patients who are currently participating in another clinical trial or have participated in another clinical trial within 30 days of the screening date
- Patients who is determined from investigator that participating is inappropriate because it may affect the results of the clinical trial or ethically
Who the study is looking for
- Adults over age 19
- Patients diagnosed with acute ischemic stroke within 7 days of symptom onset
- Patient's condition confirmed to have an acute ischemic stroke and also brain blood vessels condition confirmed through brain imaging such as Brain CT/CTA/CT perfusion and Brain MRI/MRA
- Patients voluntarily agree to participate and scheduled to participate in this clinical trial
- Patients willing to comply with the clinical trial protocol
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Soonchunhyang University Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
| Seoul National University Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.